Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

T Rowe Price Health Sciences Fd: (MF: PRHSX)

(MF) As of Jul 30, 2014 06:05 PM ET

 Add to portfolio

$66.03 USD

+0.20 (0.30%)

Zacks MF Rank : 4 - Sell [?]       4  

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jun 30, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Jun 30, 2014) 10.64
Objective* Health Care - Equity
Peer* HL MG

*Key

Zacks Premium Research for PRHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Sell 4
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 39.81
Net Assets (Mil $) 6/30/2014 8,578.00
%Turnover 6/30/2014 45.70

Allocation

% of Portfolio
Large Growth 56.96
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 20.02
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 6/30/2014 % of Portfolio
Health 47.75
Services 14.70
Finance 11.78
Retail Trade 7.10
Industrial Cyclical 6.42
Other 5.77
Technology 5.58
Non-Durable 0.90

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 6.10 569.25
ALEXION PHARMACEUTICALS I 4.63 432.06
UNITEDHEALTH GROUP INC 4.30 401.00
BIOGEN IDEC INC 3.51 327.01
MCKESSON CORP 3.24 302.45
AETNA INC 3.11 290.08
VALEANT PHARMACEUTICALS 2.95 275.21
AGILENT TECHNOLOGIES INC 2.64 246.35
INCYTE PHARMACEUTICALS IN 2.52 234.94

Stock Holding % of Net Assets

As Of 3/31/2014
Total Issues 145
Avg. P/E 26.91
Avg. P/Book 4.72
Avg. EPS Growth 15.29
Avg. Market Value (Mil $) 37,343

Risk

3 Year 5 Year 10 Year
Beta 0.94 0.91 0.88
Alpha 10.92 9.83 8.00
R Squared 0.56 0.62 0.63
Std. Dev. 15.51 15.52 16.54
Sharpe 1.86 1.89 1.00